cowX
Case study · Titan2 Film

An independent film studio wanted bigger clients. We found them.

Titan2 Film is an independent studio based in Ireland. Its co-founder, Ian, came to me needing more of the right work. Here’s how we went from a profile of the ideal client to named companies, a reason to get in touch with each one, and the first message in Ian’s own voice.

Client
Titan2 Film
Target sector
Medtech and health innovation
Region
Ireland first, then outward
What we did
Targeting, research, first contact

xxxxxx Target companies and people are redacted or generalised. Titan2 Film appears with permission.

The brief

Ian knows the work Titan2 does best: films for people building something genuinely new. What he didn’t have was a list of named companies, the time to work out who to talk to inside each one, or a reason they’d want to hear from a small studio right now.

Before any targeting, we did the groundwork on why clients choose Titan2. That pointed to the segment where its record counts most: health and medical innovation, where companies are constantly launching, expanding, winning approvals and changing leaders.

From 25 companies to the 3 to approach first

  1. Phase 01 Identify 25 candidate companies found from public sources, each matched to the client profile.
  2. Phase 02 Prioritise 10 strongest companies, after researching all 25 for fit, a live signal and a named contact.
  3. Phase 03 Open the conversation 3 companies with the sharpest moment, ready to approach, each with a LinkedIn note and email in Ian’s voice.

Phase 01

Identify

There was no list to start from. We also didn’t decide in advance what would count as a good reason to get in touch. So we went looking: weekly industry news, company announcements and funding trackers, checking every company against the client profile and backing every fit with a named source.

The reasons turned out to be as varied as the companies: a move into a new market, a first product in patients’ hands, a commercial milestone, a launch, new money. Anything that looked risky was flagged for Ian, not quietly dropped.

  • 10Ireland
  • 3UK and rest of Europe
  • 10Rest of the world
  • 2Flagged as poor fit

Phase 1 candidate target review sheet

Showing 6 of 25 rows
AccountFit rationaleFlags
xxxxxxxxMARKET ENTRYClinical-software company opening its European base in Ireland. A health innovator arriving on Titan2’s doorstep.Software, not a device. The visual story may be thinner.
xxxxxxCOMMERCIAL LAUNCHEndoscopy device company. First commercial procedures in Europe, with striking procedure footage to work with.Headquarters not confirmed. Check before treating it as European.
xxxxxxxxxxxMILESTONELarge UK medtech platform. A major procedure milestone and a new rollout across Europe.Large and established. Probably has an agency already.
xxxxxxFUNDINGUK digital-therapeutics company. New funding this quarter, and a strong patient-recovery story.None
xxxxxxxxFUNDINGHome-diagnostics platform scaling up after a growth round. Strong device-demo material.Outside the home region. Weigh against the plan.
xxxxxxxxxxPRODUCT LAUNCHGlobal medtech group launching a new cardiology system.Poor fit Buying sits with a global team, not a local relationship.

Ian reviewed the full list before any deeper research began.

What we left off

Global device makers with launches in the news. A well-funded imaging marketplace with nothing to film. Very early names with no product we could verify. A shorter, honest list beats a padded one.

Phase 02

Prioritise

We researched all 25 against three questions: is it a fit, is something happening there right now, and can we identify the best person to talk to? Each was answered on its own, not blended into one score, so a big news story couldn’t hide the lack of a way in. Digging deeper turned up signals the first pass couldn’t see: new leaders, regulatory approvals, companies committing to a new market. Then we ranked them all, and the strongest 10 went forward.

  • Fit

    Does the company match the profile of a client Titan2 wins and keeps?

  • Signal

    Is something happening right now that makes Titan2 relevant? Cited, or recorded as not found.

  • Contact

    Is there a named person who owns the decision? Found from public sources, never guessed.

  • Hot All three confirmed
  • Warm One missing
  • Nurture Fit only, watch for a trigger
  • Disqualified Fit didn’t hold, or a blocker

Prioritised accounts, at a glance

Showing 8 of 25 rows
AccountCategoryNext moveWhy
Account A TOP 10International home diagnostics
 Hot Sales
Fit
A device people use at home, so the story is the patient, not the hardware.
Signal
LEADERSHIP CHANGEA new CEO, appointed alongside a growth round.
Why it matters
A new leader decides how the company is seen next. The best moment to arrive.
Account B TOP 10Clinical software, new Irish base
 Hot Sales
Fit
A health innovator putting down roots on Titan2’s doorstep.
Signal
MARKET ENTRYA new European base in Ireland, with the CEO leading it in person.
Why it matters
It needs local partners now, and the decision-maker is in the country.
Account C TOP 10UK digital therapeutics
 Hot Sales
Fit
Rehab tech whose value only shows in a patient’s recovery. That’s exactly the story Titan2 films.
Signal
FUNDINGRaised again this quarter, on top of last year’s Series A.
Why it matters
A fresh need to explain itself to clinicians and investors, with the founder reachable directly.
xxxxxxxx TOP 10Irish device company
 Hot Sales
Fit
An Irish device company with serious backing. Home turf.
Signal
FUNDINGA large raise, with its VP of Marketing named and findable.
Why it matters
Most companies only show a CEO. Here we found the person who actually commissions film.
xxxxxxxUS cardiac-monitoring company
 Hot Sales
Fit
Heart-monitoring hardware with real patient stories behind it.
Signal
REGULATORY CLEARANCEA new FDA clearance expanding what its device can detect.
Why it matters
Every new clearance is a new claim it has to explain to doctors and patients.
xxxxxxInternational endoscopy device
 Hot Sales
Fit
A procedure device with striking footage to work with.
Signal
REGULATORY APPROVALApproval to begin a pivotal US trial.
Why it matters
A strong moment, but its headquarters turned out to be further from home than the first pass thought. We checked, and corrected it.
xxxxxxxxxxxLarge UK medtech platform
 Warm Unclear
Fit
An established medtech brand with a real milestone story.
Signal
MILESTONEA procedure milestone and a European rollout.
Why it matters
A new CEO at a large company isn’t a realistic first door for a small studio.
xxxxxxxxxxGlobal multinational
 Disqualified None
Fit
On paper only: a big investment at an Irish site.
Signal
SITE INVESTMENTNew investment at an Irish site.
Why it matters
Creative buying runs through global marketing. There’s no local door to knock on.

Where the judgement showed

Most companies on the list had something happening. Ranking them, and knowing which ones to leave out, is what decided the top 10.

  • Two multinationals disqualified. Their buying runs through global teams, not a relationship a small studio can build.
  • Two big names marked Unclear and kept out of the top 10. A fit on paper isn’t a way in.
  • Six factual discrepancies flagged, not smoothed over. One company’s headquarters turned out to be on a different continent from where the first pass placed it.
Every signal and every contact cited to a source.

Phase 03

Open the conversation

From the top 10, we took the three with the sharpest moment and got started. Each gets a LinkedIn note Ian sends himself and a short email in his name, and nothing goes out until he’s approved it. Here’s one of the emails, redacted.

Account B

Clinical-software company, opening its European base in Ireland

HotSales
The moment
MARKET ENTRYA new European base in Ireland, with the CEO leading it in person.
Who
xxxxxxxxxxx, CEO and Co-founder
The angle
Every newcomer’s first-year problem: nobody here knows who you are yet.

Written in Ian’s voice, from Titan2’s own tone-of-voice guide. Yours would sound like you.

Email92 words

Subject: Welcome to Ireland

Hi xxxxx,

Welcome to Ireland. I saw xxxxxxx chose it for its European base, and that you’re leading it yourself.

Every company that sets up here hits the same wall in year one: nobody here knows who you are yet. Not the people you want to hire, not the partners, not the customers.

A good film fixes that faster than anything else I know. I’m Ian, co-founder of Titan2 Film, a studio here that makes films for health innovators.

If a coffee would help while you settle in, it’s on me.

Ian

The highlighted line is the insight that earns a reply. The wording changes for every client. The thinking doesn’t.

“The first outreach I’ve been proud to put my name to.”

“I make films. Finding clients was never part of the craft. Ed did for us what we try to do for every client: he found what was true about each company before saying a word to them. And he showed me where every reason came from. I trust it because I can check it.”
Ian Sorensen · Co-founder, Titan2 Film

Name one company. I’ll show you how we’d get in.

Tell me one big company you’d love to win, or just the industry. I’ll take a look and talk you through what I found. On me. No strings.

Name your next big client